AI Verdict
OBIO has stronger fundamentals based on our AI analysis.
OCEA vs OBIO Fundamental Comparison
| Metric | OCEA | OBIO |
|---|---|---|
| Revenue | $-2.0M | $33.5M |
| Net Income | $-8.2M | $-52.7M |
| Net Margin | 402.7% | -157.4% |
| ROE | N/A | -98.4% |
| ROA | -520.9% | -45.9% |
| Current Ratio | 0.06x | 6.45x |
| Debt/Equity | N/A | 0.28x |
| EPS | $-0.09 | $-1.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
OCEA vs OBIO: Frequently Asked Questions
Is OCEA or OBIO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), OBIO has stronger fundamentals. OCEA is rated STRONG SELL (89% confidence) while OBIO is rated SELL (74% confidence). This is not investment advice.
How does OCEA compare to OBIO fundamentally?
Ocean Biomedical, Inc. has ROE of N/A vs Orchestra BioMed Holdings, Inc.'s -98.4%. Net margins are 402.7% vs -157.4% respectively.
Which stock pays higher dividends, OCEA or OBIO?
OCEA has a dividend yield of N/A or no dividend while OBIO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in OCEA or OBIO for long term?
For long-term investing, consider that OCEA has STRONG SELL rating with 89% confidence, while OBIO has SELL rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about OCEA vs OBIO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OCEA vs OBIO, the AI consensus favors OBIO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.